The Prognostic Value of Neuroendocrine Differentiation in Adenocarcinoma of the Prostate in Relation to Progression of Disease After Endocrine Therapy
- 1 July 1997
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 158 (1) , 171-174
- https://doi.org/10.1097/00005392-199707000-00054
Abstract
Purpose: We evaluated the prognostic impact of neuroendocrine differentiation in prostate cancer with regard to the onset of endocrine therapy failure.Materials and Methods: A retrospective...Keywords
This publication has 21 references indexed in Scilit:
- The Prostatic Endocrine-Paracrine (Neuroendocrine) Regulatory System and Neuroendocrine Differentiation in Prostatic Carcinoma: A Review and Future Directions in Basic ResearchJournal of Urology, 1994
- Management of Cancer of the ProstateNew England Journal of Medicine, 1994
- Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progressionCancer, 1994
- Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinomaCancer, 1993
- Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancerCancer, 1992
- Small Cell Anaplastic Carcinoma of the Prostate: A Clinical, Pathological and Immunohistological Study of 27 PatientsJournal of Urology, 1992
- Neuro‐endocrine Cells—A New Prognostic Parameter in Prostate CancerBritish Journal of Urology, 1991
- Prostatic Carcinoma: Histological and Immunohistological Factors Affecting PrognosisBritish Journal of Urology, 1990
- The course of neuroendocrine differentiation in prostatic carcinomasPathology - Research and Practice, 1989
- Peptide-Hormone- And Serotonin-Immunoreactive Tumour Cells in Carcinoma of the ProstatePathology - Research and Practice, 1987